CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Barclays Global Healthcare Conference Transcript

Mar 12, 2020 / 12:30PM GMT
Release Date Price: R$27.06 (-6.91%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Good morning. Welcome to Day 3 of the Barclays Global Healthcare Conference. I'm Steven Valiquette, the health care services analyst here at Barclays. We have a pretty strong lineup of companies here at the conference today.

Our first session this morning will feature CVS Health. And we're pleased to have from the company, Eva Boratto, the CFO; as well as Alan Lotvin, the EVP and Chief Transformation Officer. And also Valerie Haertel from Investor Relations is on the line as well.

So thank you all for your flexibility around the change in our conference venue, and welcome.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

So let's start with comments around coronavirus. So obviously, this is very topical for investors right now. So let's talk about how this might impact the various parts of your business the way you see it right now, and if it's possible, to segment it into Retail and Long-term Care

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot